French healthcare, the brand of healthcare industry abroad

Lyslie Legendre, Senior Trade Advisor, Business France Malaysia - 22-mars-2017 04:13:51
Matthias Fekl, Minister of State for Foreign Trade, the Promotion of Tourism and French Nationals Abroad, and Jean-Marie Le Guen, Secretary of State for Development and Francophonie, opened the conference on French Healthcare expertise on the 15 th of March in Paris. The conference, which brought together the main players in the French healthcare industry, was the occasion to launch the brand "French Healthcare". The result of a public and private initiative, this "export label" aims to take a new step in promoting the French offer. Health products are France’s third-largest export market with € 28,7 billion and a positive contribution to France’s trade balance of € 3.3 billion in 2015. France hosts four of the world’s 25 most innovative public research institutes according to the Thomson-Reuters rankings.    

Grand re-opening of Ligne Roset at Starhill Gallery

Lyslie Legendre - 04-avr.-2016 05:10:29
Following a makeover, the French modern furniture house Ligne Roset has just reopened its flagship boutique at Starhill Gallery. The new space was unveiled during an event officiated by Bernard Vinson, Export Director and Ligne Roset Malaysian business partners.  

Visit of French Ambassador and delegation to Sarawak

Kim Hwa KHOO - 26-févr.-2016 10:34:08
French Ambassador to Malaysia His Excellency Christophe Penot, together with the French Trade Commissioner Mr. Nasser El Mamoune, Economic Counsellor Mr. Arnaud Boulanger, and the French Honorary Council in Kuching Ms. Audry Wan Ullok, paid a courtesy call on the Head of State of Sarawak, His Excellency Tun Pehin Sri Haji Abdul Taib Mahmud, and the Chief Minister of Sarawak, Datuk Patinggi Tan Sri Haji Adenan Satem on 24 th February 2016.   HE Christophe Penot encouraged Malaysia and other palm oil producing countries to lobby harder for the palm oil to penetrate European markets. The French research institute CIRAD (the French Agricultural Research and International Cooperation Organisation Working for the Sustainable Development of Tropical and Mediterranean Regions) would be an ideal launching pad for palm oil producers to reach out to European consumers. It is important for the consumers in Europe to have deeper understanding of the oil palm plantations set up based on scientific findings, where researchers from CIRAD have made positive reports on palm oil.   Sources:  

MAISON&OBJET Paris : The major trade show of lifestyle experience is celebrating its 20th anniversary!

Lyslie Legendre - 14-janv.-2016 09:54:54
MAISON & OBJET Paris  : the major event for professionals working in the art of living MAISON & OBJET is the major event for professionals working in the art of living in all its rich and varied expressions. The lifestyle show brings together a 360°product offering :   Decoration, design, furniture, accessories, textiles, fragrances, the world of children, tableware… The styles coexist in a multifaceted way, throughout the inventive show design which enlivens the spaces. This extraordinary diversity is in line with the varied expectations of global markets.   From 22nd and 26th January 2016 at Paris Nord Villepinte    

«Immersion France» : a new application to support the promotion of linguistic offers for tourists, students or schoolchildren

Lyslie Legendre - 14-janv.-2016 09:38:10
The linguistic tourism generates 1 million nights and a turnover of over 115 million Euros every year. IMMERSION FRANCE launched by Campus France in order to improve the visibility of French offer worldwide is : - an application for mobiles and tablets which is multilingual, free and easy to access; - a directory listing the best offers of language centres in France: Qualité Français Langue Étrangère (French as Foreign Language Quality) label, Qualité Unosel (Unosel Quality) label, Office quality contract and institutions member of the Campus France Forum; - a support to decide which tailor-made stay to choose; - an interactive map to discover the French regions; - over 100 promotion pictures and videos;hundreds of stay offers detailing learning of French language and cuisine, tourist travels and trainings   - hundreds of stay offers detailing learning of French language and cuisine, tourist travels and trainings.

Malaysian Medical Device Authority Issues Draft Incident Reporting Structure

Hairel Abbie - 26-nov.-2015 04:17:13
  Malaysia’s Medical Device Authority, a division of the Malaysian Ministry of Health, has just issued a first edition of a draft guidance document (MDA/GD/0014) on Mandatory Problem Reporting for medical devices. The guidance document relates to medical devices (but not those in clinical investigations) and IVDs; establishments; and users and others concerned with the continuing safety of medical devices. The MDA is encouraging a no-blame culture and says the act of reporting an incident to the authority is not to be construed as an admission of liability for the incident and its consequences. The proposed timelines for problem reporting are as follows: Type of incident   Timeframe in which incident has to be reported   For incidents that represent a serious threat to public health   48 hours   For incidents that has led to the death, or a serious deterioration in the state of health, of a patient, a user of the medical device or any other person   10 days   For incidents where a recurrence of which might lead to the death, or a serious deterioration in the state of health, of a patient, a user of the medical device or any other person   30 days   After that, medical establishments are to follow up with a final report within 30 days of the initial reports or within a timeframe as allowed by the MDA, detailing the investigation into the incident and the outcome. Familiar Terms Familiar terms within the context of international harmonization efforts in the field of device reporting are recognized in Malaysia and explained in the guidance document. These terms include: field corrective action and field safety notice, indirect harm, final reports and trend reporting. The authority will also sometimes agree periodic follow-up reporting with manufacturers or authorized representatives for certain types of device and incident, although with trigger points if certain levels are exceeded. As a general principle, there should be a pre-disposition to report, rather than not. Moreover, any incident, which meets the three basic reporting criteria listed below, is considered as reportable: a) an incident has occurred; b) the medical device is associated with the incident; and c) the incident led to one of the following outcomes; i) a serious threat to public health; ii) death of a patient, user or other person; iii) serious deterioration in state of health, user or other person; or iv) no death or serious injury occurred but the incident might lead to death or serious injury of a patient, user or other person if the incident recurs. The draft guidance document states that in assessing the link between the device and the incident the manufacturer should take account of the opinion, based on available evidence, of healthcare professionals; the results of the manufacturer’s own preliminary assessment of the incident: evidence of previous, similar incidents; and other evidence held by the manufacturer. It states that this judgement may be difficult when there are multiple devices and drugs involved. In complex situations, it should be assumed that the device may have caused or contributed to the incident, the draft states. The MDA considers it would want to be notified where: an incident associated with a medical device happened, and, if it occurred again, it might lead to death or serious deterioration in health; or testing, examination of the medical device, information supplied with the medical device, or any scientific literature indicated some factor (eg deterioration in characteristics or performance, or a shortcoming in the information) which could lead to an incident involving death or serious deterioration in health. The MDA also points out that where companies merge or buy each other out and the vigilance and other post-market surveillance obligations are being transferred to another legal entity, it is important that post-market surveillance and vigilance activities continue and that the MDA is appraised of the implications and provided with new contact details as soon as possible IVDs And Further Information In the case of IVDs, the type of incidents that should be reported include: misdiagnosis; delayed diagnosis; delayed treatment; inappropriate treatment; and transfusion of inappropriate materials. In addition, the MDA indicates in its draft that: where an incident occurs as a consequence of the combined use of two or more separate devices (and/or accessories) made by different manufacturers, each manufacturer or authorised representative should submit a report to the MDA; manufacturers should keep their conformity assessment body (CAB) advised of issues occurring in the post production phase which may affect the certification. This would include relevant changes derived from the vigilance system. The draft guidance document, which fits within the framework of Malaysia’s 2012 Medical Device Act, and will remain relevant within the context of the country’s forthcoming Medical Device Regulation, gives a series of examples where reporting is not required, including use error reports. Source : Clinica  

Join the 4th edition of BioFit on December 1st & 2nd 2015 in Strasbourg, France

Lyslie Legendre - 21-oct.-2015 10:21:43
BIOFIT is the leading business convention in Europe for open Innovation, technology transfer and collaborative research in Life Sciences. More than 1300 participants will attend the 2015 edition, which will be held in Strasbourg (Alsace region), at the heart of the Franco-German-Swiss BioValley Cluster, a center of excellence for therapeutic innovation I   Public & Private collaborations BioFIT is the leading partnering event in Europe for Open Innovation, technology transfer and collaborative research in the field of Life Sciences, with the highest attending rate of academia, TTOs and research institutes together with big pharma, emerging and small biotech companies, medtech and diagnostics companies. Engage new partnerships Foster the emergence of collaborative projects Intensify the flow of licenses in the field of life sciences Who will you meet? The event gathers leaders from pharma, biotech, medtech, IVD companies, investors, as well as professionals from technology transfer and academia. Website : Registration for Biofit :
Welcome to the French Trade Commission – Business France office in Malaysia! “Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. Founded on January 1, 2015 through a merger between UBIFRANCE and the Invest in France Agency, Business France has 1,500 personnel, both in France and in 70 countries throughout the world, who work with a network of public- and private-sector partners.” As a member of the French diplomatic network in Malaysia, Business France’s three missions are: - Fostering export growth by French businesses. - Promoting and facilitating international investment in France.


Press area & Media Gallery